Clients in the Media

October 23, 2025 | Interius
First patient dosed with in vivo CAR-T therapy
STAT
October 1, 2025 | RadioMedix
Radiopharma pipeline builds ahead of key data
Nature Cancer
September 3, 2025 | RadioMedix
Radiopharma’s big year: Interview with RadioMedix CEO Dr. Delpassand
Labiotech
August 21, 2025 | Interius
Gilead joins the in vivo cell therapy race with $350M buyout of Interius
Endpoints
June 12, 2025 | RadioMedix
Former MD Anderson researcher unveils tech to ‘democratize’ access to cancer research
The Houston Business Journal
May 27, 2025 | AP Biosciences
AP Bio heads to phase I with bispecific for HER2-resistant tumors
BioWorld